Clinical Trial Update: Effects of Antithymocyte Globulin in Adults With Myelodysplastic Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update examining the effects of Antithymocyte Globulin in adults with myelodysplastic syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome

Drugs mentioned

• Antithymocyte Globulin (anti-thymocyte globulin)

Snippet

Sponsor: Office of Rare Diseases (ORD) | Conditions: Myelodysplastic Syndrome | Phase 2 | Status: UNKNOWN